Clinical, Neurohormonal, and Inflammatory Markers and Overall Prognostic Role of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure: Data From the Val-HeFT Heart Failure Trial
- 31 December 2007
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Cardiac Failure
- Vol. 13 (10), 797-804
- https://doi.org/10.1016/j.cardfail.2007.07.012
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Definition, epidemiology, and risk factorsBMJ, 2006
- Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary diseaseEuropean Heart Journal, 2005
- Therapeutic Update: Non-Selective Beta- and Alpha-Adrenergic Blockade in Patients With Coexistent Chronic Obstructive Pulmonary Disease and Chronic Heart FailureJournal of the American College of Cardiology, 2004
- The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFTEuropean Heart Journal, 2004
- Uncovering Heart Failure in Patients with a History of Pulmonary Disease: Rationale for the Early Use of B-type Natriuretic Peptide in the Emergency DepartmentAcademic Emergency Medicine, 2003
- Cardiac troponins in renal insufficiencyJournal of the American College of Cardiology, 2002
- A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart FailureNew England Journal of Medicine, 2001
- Trends in hospitalization for heart failure in Scotland, 1990–1996. An epidemic that has reached its peak?Published by Oxford University Press (OUP) ,2001
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- Studies of Left Ventricular Dysfunction (SOLVD)—Rationale, design and methods: Two trials that evaluate the effect of enalapril in patients with reduced ejection fractionThe American Journal of Cardiology, 1990